Working… Menu

Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03951259
Recruitment Status : Recruiting
First Posted : May 15, 2019
Last Update Posted : September 4, 2019
Jiangsu ZuoYou Medicine Co., Ltd.
Information provided by (Responsible Party):
RenJi Hospital